探索midodrine对减轻血管压缩器的有效性
Zoraize Moeez Athar1, Mahnoor Arshad1, Shitij Shrivastava1
1Internal Medicine, BronxCare Health System, New York, USA.
Cureus
|April 1, 2024
概括
口服血管压缩剂米多德林 (Midodrine) 正在研究其在重症监护室 (ICU) 患有败血症和败血性休克的患者的有效性. 关于它有助于帮助患者戒除血管压缩剂并提高生存率的能力,证据是混合的.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 败血症和败血性休克经常需要在ICU中提供血管压缩器支持.
- 作为一种口服血管压缩剂的米多德林 (Midodrine) 正在作为一种辅助疗法进行研究,以促进血管压缩剂的断奶.
- 关于米多德林在改善临床结果方面的有效性,存在相互矛盾的证据.
研究的目的:
- 综合审查现有的关于中素在ICU环境中的作用的文献.
- 评估来自多中心试验,回顾性研究和元分析的证据.
- 评估midodrine在治疗败血症和败血性休克方面的潜在好处和缺点.
主要方法:
- 文献综述包括多中心试验,回顾性研究和元分析.
- 综合证据关于 midodrine 对血管压缩剂断奶,ICU/住院停留和死亡率的影响.
- 分析数据以确定研究结果中的趋势和不一致性.
主要成果:
- 一些研究表明,midodrine在加速血管压缩器断奶和减少停留时间方面具有有限的益处.
- 其他研究表明潜在的优势,包括降低败血症休克患者的死亡率.
- 在这种重症监护背景下,midodrine的整体疗效和安全性状况仍在调查中.
结论:
- 需要进一步澄清中素作为ICU患者的辅助疗法的作用,这些患者有败血症和败血性休克.
- 需要进行额外的研究,以解决有关其有效性,最佳使用和安全性的知识差距.
- 目前正在进行的研究旨在提供明确的证据,证明米多德林对患者的治疗结果和资源利用的影响.
关键词:
低血压是因为低血压.这是一个ICU.重症监护病房的重症监护病房是一个重症监护病房.第四个是IV.第四种血管压缩剂中氨酸是什么?中氨酸是什么?这是一种血症.败血症的冲击是一个令人震惊的现象.血管压缩器是一种压缩器.断奶 断奶 断奶 断奶 断奶更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.8K
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
8.9K
相关概念视频
01:23Antihypertensive Drugs: Vasodilators
516
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
516
01:30Adrenergic Agonists: Therapeutic Uses
770
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
770
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:18Adrenergic Agonists: Therapeutic Classification
778
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
778
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
313
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
313